ArticleCancer research2013

GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors.

Andrea Morandi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.